305 related articles for article (PubMed ID: 29893036)
1. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
[TBL] [Abstract][Full Text] [Related]
3. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells after neoadjuvant chemotherapy are related with recurrence in esophageal squamous cell carcinoma.
Ujiie D; Matsumoto T; Endo E; Okayama H; Fujita S; Kanke Y; Watanabe Y; Hanayama H; Hayase S; Saze Z; Ohki S; Kono K
Esophagus; 2021 Jul; 18(3):566-573. PubMed ID: 33661456
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
6. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
Han L; Li YJ; Zhang WD; Song PP; Li H; Li S
Medicine (Baltimore); 2019 Feb; 98(6):e13921. PubMed ID: 30732126
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of TWIST-Positive Circulating Tumor Cells in Patients with Esophageal Squamous Cell Carcinoma.
Lee HJ; Kim GH; Park SJ; Kwon CH; Lee MW; Lee BE; Baek DH; I H
Gut Liver; 2021 Jul; 15(4):553-561. PubMed ID: 33293482
[TBL] [Abstract][Full Text] [Related]
12. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
14. Detection of Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells in Patients with Esophageal Squamous Carcinoma.
Han D; Chen K; Che J; Hang J; Li H
Biomed Res Int; 2018; 2018():7610154. PubMed ID: 30046606
[TBL] [Abstract][Full Text] [Related]
15. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report.
Qiao YY; Lin KX; Zhang Z; Zhang DJ; Shi CH; Xiong M; Qu XH; Zhao XH
World J Gastroenterol; 2015 Jul; 21(25):7921-8. PubMed ID: 26167094
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma.
Lam AK; Hamid FB; Gopalan V
Methods Mol Biol; 2020; 2129():193-202. PubMed ID: 32056179
[TBL] [Abstract][Full Text] [Related]
18. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
19. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
Liu YK; Hu BS; Li ZL; He X; Li Y; Lu LG
Hepatol Int; 2016 Jul; 10(4):640-6. PubMed ID: 27115761
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]